# ![@janthecurious1 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1471510678561169415.png) @janthecurious1 Jan

Jan posts on X about $nvo, novo, nvo, in the the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::1471510678561169415/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1471510678561169415/c:line/m:interactions.svg)

- [--] Week [-----] -65%
- [--] Month [------] -23%
- [--] Months [-------] +31%
- [--] Year [-------] +161%

### Mentions: [--] [#](/creator/twitter::1471510678561169415/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1471510678561169415/c:line/m:posts_active.svg)

- [--] Week [--] -71%
- [--] Month [--] +43%
- [--] Months [---] +206%
- [--] Year [---] +164%

### Followers: [---] [#](/creator/twitter::1471510678561169415/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1471510678561169415/c:line/m:followers.svg)

- [--] Week [---] +0.54%
- [--] Month [---] +3.40%
- [--] Months [---] +17%
- [--] Year [---] +48%

### CreatorRank: [---------] [#](/creator/twitter::1471510678561169415/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1471510678561169415/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  68% [finance](/list/finance)  20% [countries](/list/countries)  9% [currencies](/list/currencies)  5% [travel destinations](/list/travel-destinations)  3% [social networks](/list/social-networks)  2% [celebrities](/list/celebrities)  2% [technology brands](/list/technology-brands)  1% [gaming](/list/gaming)  1% [products](/list/products)  1%

**Social topic influence**
[$nvo](/topic/$nvo) #75, [novo](/topic/novo) #2370, [nvo](/topic/nvo) #24, [in the](/topic/in-the) 9%, [strong](/topic/strong) 9%, [ceo](/topic/ceo) 8%, [$grvy](/topic/$grvy) 8%, [products](/topic/products) 6%, [$3765t](/topic/$3765t) 6%, [this is](/topic/this-is) 5%

**Top accounts mentioned or mentioned by**
[@investseekers](/creator/undefined) [@researchpulse1](/creator/undefined) [@bruuntonny](/creator/undefined) [@stockmktnewz](/creator/undefined) [@madssparholt](/creator/undefined) [@freddiewittmann](/creator/undefined) [@kazukimorishita](/creator/undefined) [@kuennisk](/creator/undefined) [@amaymd](/creator/undefined) [@serenawilliams](/creator/undefined) [@ro](/creator/undefined) [@oprah](/creator/undefined)

**Top assets mentioned**
[Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [WW International, Inc. Common Stock (WW)](/topic/$ww) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Morgan Stanley (MS)](/topic/morgan-stanley)
### Top Social Posts
Top posts by engagements in the last [--] hours

"#novonordisk $nvo Novo Nordisk is warming up for the Super Bowl this Sunday on Instagram teasing a star-studded journey with names like DJ Khaled Danny Trejo Ana Gasteyer and Danielle Brooks popping up along the way. All signs point to something big - this is going to be huge. 🏈🔥 https://twitter.com/i/web/status/2019354131106869679 https://twitter.com/i/web/status/2019354131106869679"  
[X Link](https://x.com/anyuser/status/2019354131106869679)  2026-02-05T10:15Z [---] followers, [---] engagements


"#novonordisk $nvo Novo continues to add sales momentum. TrumpRX implements the Dec-2025 agreement driving volume and distribution rather than policy change. https://www.reuters.com/business/healthcare-pharmaceuticals/trump-unveil-trumprx-website-thursday-2026-02-05/ https://www.reuters.com/business/healthcare-pharmaceuticals/trump-unveil-trumprx-website-thursday-2026-02-05/"  
[X Link](https://x.com/anyuser/status/2019652497896300949)  2026-02-06T06:00Z [---] followers, [---] engagements


"#novonordisk $nvo Novo's pill and the TrumpRX deal finally put an end to these copycats including HIMS. Now all we need is for them to withdraw from the Super Bowl and the multi-billion dollar lawsuit so Novo can recover their losses over the years. A victory for the rule of law and humanity. Today the FDA is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies including Hims & Hers and other compounding pharmacies as similar https://t.co/2KMBRodPvV Today"  
[X Link](https://x.com/anyuser/status/2020036734088614224)  2026-02-07T07:27Z [---] followers, [---] engagements


"Data delivered. Regulation follows. Next chapter for CagriSema is simple: sell sell sell. #NovoNordisk $nvo 🚀📈"  
[X Link](https://x.com/anyuser/status/2018363966414614941)  2026-02-02T16:40Z [---] followers, [---] engagements


"#novonordisk $nvo Short summary: Novo Nordisk publicly attacks Hims & Hers for planning to mass-market an unapproved copy of a semaglutide pill. Novo claims illegal compounding an untested product patient safety risks and prior FDA warnings. Legal action signaled. Fraud again from #Hims https://twitter.com/i/web/status/2019441934343762363 https://twitter.com/i/web/status/2019441934343762363"  
[X Link](https://x.com/anyuser/status/2019441934343762363)  2026-02-05T16:04Z [---] followers, [---] engagements


"#novonordisk $nvo The FDAs statement is a direct warning to HIMS. The typical next steps are marketing bans and sales suspensions for illegal copycat drugs. This is not about competition with Wegovy - its about regulatory enforcement. Novo holds the patents approvals and the FDAs backing. https://www.reuters.com/legal/litigation/fda-take-action-companies-marketing-illegal-copycat-drugs-fda-chief-says-2026-02-05/ FDA will take swift action against companies mass-marketing illegal copycat drugs claiming they are similar to FDA-approved products. The FDA cannot verify the quality safety or"  
[X Link](https://x.com/anyuser/status/2019633003442372900)  2026-02-06T04:43Z [---] followers, [---] engagements


"#novonordisk $nvo Enough is enough. Novo is filing a lawsuit against HIMS. This must be the death knell for HIMS. I think there will be an upgrade from Novo before Q1 [----] ends. Novo has the backing of the FDA and a long list of health organizations in the US. The substances that HIMS sells are full of impurities. https://twitter.com/i/web/status/2020844928062906407 https://twitter.com/i/web/status/2020844928062906407"  
[X Link](https://x.com/anyuser/status/2020844928062906407)  2026-02-09T12:59Z [---] followers, [---] engagements


"After this weeks JPM Healthcare Conference its clear that Zealand Pharma continues to position itself strongly within obesity and metabolic diseases. The focus was not on short-term news but on long-term strategy a broad and differentiated pipeline and the ability to develop next-gen peptides including through partnerships. This reinforces my investment thesis and the stock is part of my portfolio. High scientific quality capital discipline and clear upcoming clinical milestones make it a company worth following closely. $ZEAL.CO #ZealandPharma #Biotech #Obesity #MetabolicDisease"  
[X Link](https://x.com/janthecurious1/status/2012119273297064093)  2026-01-16T11:06Z [---] followers, [---] engagements


"#novonordisk $nvo Come on. Past [--] next stop [--] 🚀 I don't use technical analysis but I do look at it occasionally"  
[X Link](https://x.com/janthecurious1/status/2012173915733234153)  2026-01-16T14:43Z [---] followers, [----] engagements


"#Novonordisk $nvo Continued hiring freeze at Novo could through natural attrition free up USD 310470m per year all else equal potentially supporting share buybacks. Photo: AI"  
[X Link](https://x.com/janthecurious1/status/2015801978954129761)  2026-01-26T15:00Z [---] followers, [----] engagements


"This is about a deliberate change in principle. CEO Mike Doustdar has changed the guidance methodology and now excludes sales rebates from the forecast. If rebates were included: [----] sales: approx. 1% Operating profit: approx. +11% which is very strong. Guidance is set extremely conservatively. An upgrade looks like a question of when"  
[X Link](https://x.com/janthecurious1/status/2018755394479305055)  2026-02-03T18:36Z [---] followers, [----] engagements


"This is about a deliberate change in principle. CEO Mike Doustdar has changed the guidance methodology and now excludes sales rebates from the forecast. If rebates were included: [----] sales: approx. 1% Operating profit: approx. +11% - which is very strong. Guidance is set extremely conservatively. An upgrade looks like a question of when. https://twitter.com/i/web/status/2018756089907499517 https://twitter.com/i/web/status/2018756089907499517"  
[X Link](https://x.com/janthecurious1/status/2018756089907499517)  2026-02-03T18:38Z [---] followers, [----] engagements


"#novonordisk $nvo Great interview with Mike. Clear and powerful answers to great questions. https://www.foxbusiness.com/video/6389074266112 https://www.foxbusiness.com/video/6389074266112"  
[X Link](https://x.com/janthecurious1/status/2021638076968448083)  2026-02-11T17:30Z [---] followers, [---] engagements


"@StockMKTNewz [--] million people isnt a number - its a distance. Put them in a single line and you get [----] km. Thats Copenhagen India. This is the scale were talking about. $nvo #novonordisk"  
[X Link](https://x.com/janthecurious1/status/2021669400181657919)  2026-02-11T19:35Z [---] followers, [---] engagements


"@investseekers Nice offensive moves. So Novo's Outlook for [----] was way too pessimistic. CEO Mike D. chose not to include all the new initiatives in Outlook 2026"  
[X Link](https://x.com/janthecurious1/status/2021976565286871125)  2026-02-12T15:55Z [---] followers, [---] engagements


"#Novonordisk $nvo The U.S. wont be Novos bottleneck - it becomes the engine. With Jamey Millar Novo gains payer insight from the inside lower political friction and better monetization of the obesity franchise. Outcome: higher quality growth and a more durable premium multiple. https://www.berlingske.dk/virksomheder/novo-nordisks-finanschef-er-brandaergerlig-over-at-skuffe-investorerne-men-paa-et-punkt-er-han-optimistisk https://www.berlingske.dk/virksomheder/novo-nordisks-finanschef-er-brandaergerlig-over-at-skuffe-investorerne-men-paa-et-punkt-er-han-optimistisk"  
[X Link](https://x.com/anyuser/status/2018822688320455052)  2026-02-03T23:03Z [---] followers, [---] engagements


"#novonordisk $nvo Ive reread the FDA statement. Enough is enough. This is not just about Novos pills. It also targets injectables. Platforms like Hims & Hers will with high probability be forced to halt sales of compounded Novo-like GLP-1 injections. The critical issue: Based on HIMS latest financials the company has very limited capacity to absorb large settlements damages or regulatory fines. Margins and liquidity are not built for regulatory shocks. FDA is reacting aggressively because compounding has become: 1.a mass-produced workaround 2.based on semaglutide salts (not FDA-approved"  
[X Link](https://x.com/anyuser/status/2020445065588404230)  2026-02-08T10:30Z [---] followers, [---] engagements


"#novonordisk $nvo Novo Nordisk share buyback: up to DKK 15bn over [--] months. First tranche: DKK 3.8bn (FebMay 2026). Bought so far (as of Feb 6): [------] B shares = DKK 222m"  
[X Link](https://x.com/anyuser/status/2020842611498774825)  2026-02-09T12:49Z [---] followers, [---] engagements


"$nvo Bloodbath in Amsterdam Unilever plunges as markets price in the impact of GLP-1 weight-loss drugs from Novo Nordisk. Less appetite = less Magnum snacks & junk food. Its structural disruption. #NovoNordisk #GLP1 #Unilever #Stocks #ConsumerGoods #Disruption"  
[X Link](https://x.com/anyuser/status/2022054871420272840)  2026-02-12T21:07Z [---] followers, [---] engagements


"#novonordisk $nvo Strong early signs for Novos Wegovy pill 📈 36% of patients are new to GLP-1 therapy. 21% switched from injectable Wegovy. 16% came from Eli Lillys Zepbound. Based on [----] patient records (Truveta/Reuters). Suggests both market expansion and competitive strength. https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-third-patients-wegovy-pill-are-new-glp-1-drugs-study-finds-2026-02-11/ https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-third-patients-wegovy-pill-are-new-glp-1-drugs-study-finds-2026-02-11/"  
[X Link](https://x.com/janthecurious1/status/2022595974812610976)  2026-02-14T08:57Z [---] followers, [---] engagements


"#novonordisk $nvo Novo takes another step in its efficiency strategy: Layoffs in pilot production in Northern Denmark (API for in-house clinical trials). Outsourcing efforts are being intensified. Indication of a more asset-light model in early-stage production. https://medwatch.dk/brancher/Medicinal___Biotek/article19019534.eceutm_source=chatgpt.com https://medwatch.dk/brancher/Medicinal___Biotek/article19019534.eceutm_source=chatgpt.com"  
[X Link](https://x.com/janthecurious1/status/2022748381404397906)  2026-02-14T19:02Z [---] followers, [---] engagements


"#novonordisk $Nvo Novo Nordisk secures UK approval for its haemophilia drug Alhemo (concizumab). For patients with haemophilia A or B with inhibitors. Analysts see $12 billion annual sales potential by [----] - a new growth pillar beyond diabetes and obesity. The positive market opportunities are pouring in and the share price is falling crazy. #NovoNordisk #Alhemo #Biotech #NVO"  
[X Link](https://x.com/janthecurious1/status/1981722084964184083)  2025-10-24T13:58Z [---] followers, [---] engagements


"$NVO #NovoNordisk continues to lead in cardiometabolic innovation. [--] new #MASH abstracts at AASLD. ESSENCE data suggest real improvement in liver fibrosis - not just weight loss. Competitors are playing catch-up. Novo is building the next multi-billion franchise in real time. Were nowhere near the top. 🚀"  
[X Link](https://x.com/janthecurious1/status/1983186549014495356)  2025-10-28T14:58Z [---] followers, [--] engagements


"$NVO #NovoNordisk continues to lead in cardiometabolic innovation. [--] new #MASH abstracts at AASLD. ESSENCE data suggest real improvement in liver fibrosis - not just weight loss. Novo is building the next multi-billion franchise in real time. Were nowhere near the top. 🚀"  
[X Link](https://x.com/janthecurious1/status/1983186886140297620)  2025-10-28T14:59Z [---] followers, [----] engagements


"#novonordisk $nvo Novo Nordisk strengthens its position in China: Collaboration with #Fangzhou on AI-powered diabetes & weight management launched at #CIIE. Digital health platform + medical expertise = a stronger foothold in the worlds largest diabetes market. https://www.globenewswire.com/news-release/2025/11/07/3183391/0/en/Fangzhou-Novo-Nordisk-Launch-Initiative-for-AI-Powered-Diabetes-and-Weight-Management-Solutions-at-CIIE.html"  
[X Link](https://x.com/janthecurious1/status/1986757162404548635)  2025-11-07T11:26Z [---] followers, [---] engagements


"#Novonordisk $nvo Trump gives Novo Nordisk a boost in its battle with Eli Lilly. 🚀😀 Fast-tracking the turbo version of Wegovy in the US will give Novo a clear lead - and quickly lift earnings"  
[X Link](https://x.com/janthecurious1/status/1986760888875942177)  2025-11-07T11:41Z [---] followers, [---] engagements


"@investseekers Mega clumsy communication from Novo. I think they still have too many employees in communication and too many levels so they haven't heard Mike's message"  
[X Link](https://x.com/janthecurious1/status/1986790110851895579)  2025-11-07T13:37Z [---] followers, [---] engagements


"Novonordisk $novo Good thing Novo walked away from the deal. Pfizer is tying up billions in a very uncertain project. Novo can now focus on sales its own pipeline production logistics and restart buybacks. 🚀🚀🚀💰💰💰 The new deal with Trump is a huge positive - slightly lower price but access to a whole new market segment. Brilliant move. 📈"  
[X Link](https://x.com/janthecurious1/status/1987581149984759981)  2025-11-09T18:00Z [---] followers, [---] engagements


"#novonordisk $nvo Big news from #AASLD2025: Novo Nordisks Wegovy (semaglutide [---] mg) shows liver injury improvement in #MASH patients even with minimal weight loss. Opens a potential multi-billion $ market - 250M+ people globally. #NASH #Semaglutide"  
[X Link](https://x.com/janthecurious1/status/1987883127847690639)  2025-11-10T14:00Z [---] followers, [---] engagements


"$nvo Novo Nordisk halted its share buybacks after buying around DKK [---] per share. Now the price is DKK [---] per share - and the cash pile is huge with no debt. They could buy high but not low #NovoNordisk"  
[X Link](https://x.com/janthecurious1/status/1987888091554525302)  2025-11-10T14:20Z [---] followers, [---] engagements


"$nvo Novo Nordisk expands beyond GLP-1. Phase [--] data for coramitug (ATTR-CM) support the ongoing Phase [--] CLEOPATTRA trial. A potential first-in-class therapy in a $5B market strong validation of the [----] Prothena acquisition. #NovoNordisk"  
[X Link](https://x.com/janthecurious1/status/1988276966399857008)  2025-11-11T16:05Z [---] followers, [---] engagements


"#novonordisk $nvo +1200 [-----] Novo Nordisk comeback confirmed. TrumpRx deal done ✅ Now waiting for FDA approval of oral Wegovy. EPS 2026E [--] DKK forward P/E [--] re-rating to [----] = [--------] DKK (+300 %). Novo is back. Source: Reuters Nov [--] 2025"  
[X Link](https://x.com/janthecurious1/status/1988487166591205538)  2025-11-12T06:00Z [---] followers, [---] engagements


"WeightWatchers is back on track WW is gaining momentum again - now planning to sell Novo Nordisks upcoming Wegovy pill in the US. The company already has millions of subscribers giving it a powerful distribution channel once the pill launches. 🔗 Strong potential win-win for both $WW and $NVO. #NVO #WW #Wegovy #obesitycare"  
[X Link](https://x.com/janthecurious1/status/1988713812468342809)  2025-11-12T21:01Z [---] followers, [---] engagements


"#novonordisk $nvo The general meeting was conducted with strength and clarity. The message is clear: we now have a highly competent Board of Directors ready to lead Novo into its next strategic chapter. Lars Rebien demonstrated great composure and confidence delivering his messages with clarity - and even room for a few smiles underscoring his strong command of the situation. The next step is to further strengthen the Board especially with competencies in IT and Artificial Intelligence supporting the strategy of making Novo significantly more consumer-oriented. The Chair underlined an"  
[X Link](https://x.com/janthecurious1/status/1989339663295783066)  2025-11-14T14:28Z [---] followers, [---] engagements


"#novonordisk $nvo At Novo Nordisks extraordinary general meeting Chairman Lars Rebien Srensen sent a powerful signal: GLP-1 drugs like Wegovy and Ozempic may eventually move to over-the-counter status. Such a shift would open a dramatically larger market and could significantly boost revenue. At the same time the Wegovy pill expected in early [----] looks like the first step toward broader and more accessible distribution. If GLP-1 medicines end up on pharmacy shelves without a prescription it could transform the entire industry"  
[X Link](https://x.com/janthecurious1/status/1989394756665753601)  2025-11-14T18:07Z [---] followers, [----] engagements


"#NovoNordisk $nvo Game Over Obesity Drugs Become a Consumer Product As Chairman Lars Rebien emphasized at the extraordinary general meeting obesity medicine is rapidly turning into a mainstream consumer product - increasingly something that may eventually be sold without a prescription directly to users. That shift has been dramatically accelerated by the deal Eli Lilly and Novo Nordisk struck with the Trump administration in which they accepted significant price cuts on GLP-1 drugs like Wegovy and Zepbound. In return the companies receive Medicare coverage unlocking access to millions of new"  
[X Link](https://x.com/janthecurious1/status/1990140301680263375)  2025-11-16T19:29Z [---] followers, [----] engagements


"#novonordisk $nvo Strong signal from Novo Nordisk today. Board member Stephan Engels (an economist) buys [----] B-shares for more than DKK [--] million. When an economist invests that much it says a lot about confidence in the business model"  
[X Link](https://x.com/janthecurious1/status/1990424089752744285)  2025-11-17T14:17Z [---] followers, [----] engagements


"#novonordisk $nvo CEO Mike Doustar in Copenhagen today: the Wegovy pill launches in the US in early [----] and supply wont be an issue. We have more than enough this time so were going all-in. 🚀"  
[X Link](https://x.com/janthecurious1/status/1990471555130831209)  2025-11-17T17:26Z [---] followers, [---] engagements


"#novonordisk $nvo The Alzheimers results provide clarity and allow Novo Nordisk to double down on its core strengths: obesity and type [--] diabetes. This shift frees up resources for the areas with the strongest global leadership and the largest long-term growth potential"  
[X Link](https://x.com/janthecurious1/status/1992929152425754715)  2025-11-24T12:11Z [---] followers, [---] engagements


"#novonordisk $nvo The market is hitting $NVO hard after the EVOKE results - but experts say the reaction misses the bigger picture. Ivan Koychev points out that GLP-1 drugs seem to work earliest in the Alzheimers process not in patients who already have significant damage. So the limited effect in later-stage patients was expected. Howard Fillit highlights that semaglutide still showed clear improvements in key Alzheimers markers which suggest a path forward. 📈 For Novo the opportunity isnt gone - its clearer: Focus on early-stage Alzheimers where the drug has the best chance to work Look at"  
[X Link](https://x.com/janthecurious1/status/1993202894720344450)  2025-11-25T06:19Z [---] followers, [---] engagements


"#novonordisk $nvo Amycretin is emerging as the clear successor to Wegovy. Phase [--] data show next-gen weight loss and HbA1c reductions with no plateau in sight. With the U.S. administration opening the door to faster approvals Novo Nordisk may be looking at its next flagship. Momentum is just beginning"  
[X Link](https://x.com/janthecurious1/status/1993292772317536408)  2025-11-25T12:16Z [---] followers, [---] engagements


"#novonordisk $nvo The pill is coming. [---] is in sight. 🚀"  
[X Link](https://x.com/janthecurious1/status/1993294068189974732)  2025-11-25T12:21Z [---] followers, [---] engagements


"@investseekers Stock analysts and banks cheat their clients wherever they can"  
[X Link](https://x.com/janthecurious1/status/1993580452351791557)  2025-11-26T07:19Z [---] followers, [--] engagements


"#Novonordisk $nvo The market is sleeping on what may be the biggest shift since Wegovy. Amycretin is emerging as the true next-generation breakthrough - stronger data broader potential and far harder to copy. And the oral version is already showing the kind of efficacy that can rewrite the entire obesity and diabetes landscape. With accelerated U.S. pathways now on the table the timeline for a first-in-class oral successor looks far more favorable than the market assumes. This is the early stage of a multi-year rerating. The upside is massive - and absolutely not priced in. #novonordisk $nvo"  
[X Link](https://x.com/janthecurious1/status/1995489202780127318)  2025-12-01T13:44Z [---] followers, [---] engagements


"#novonordisk $nvo WHOs backing of GLP-1 is a global game-changing signal. Were looking at a trillion-dollar health market now getting regulatory tailwinds. Novo is already at the epicenter of this structural megatrend. I believe the market still underestimates how early we are in this curve. 🚀🚀🚀 https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity"  
[X Link](https://x.com/janthecurious1/status/1995519327043223790)  2025-12-01T15:44Z [---] followers, [----] engagements


"#Novonordisk $nvo After regulators rejected it twice the situation has completely changed. With WHOs approval now in place they simply cant ignore it - and I believe this could create significant momentum potentially even a major boost in [----]. With prices coming down the business case finally makes sense for both governments and Novo. In the EU more than half of adults are overweight and around 17% are obese. Thats a massive addressable population putting enormous pressure on national healthcare systems. If this approval spreads across the EU as expected it could turn into a genuine win-win:"  
[X Link](https://x.com/janthecurious1/status/1996121333898301939)  2025-12-03T07:36Z [---] followers, [---] engagements


"#novonordisk $nvo Novo Nordisk says its too early to call game over in Alzheimers. Semaglutide shows biological effect but not enough to change symptoms - research continues. Source: Brsen Denmark [----]. Dec. 4"  
[X Link](https://x.com/janthecurious1/status/1996463740024406224)  2025-12-04T06:17Z [---] followers, [---] engagements


"@investseekers It doesn't matter that much. The US accounts for about 80% of this compared to the EU. In the US and EU the patents don't expire until 2031-2032 and then Novo is starting to sell the next generation - Amycretin"  
[X Link](https://x.com/janthecurious1/status/1998841744012751012)  2025-12-10T19:46Z [---] followers, [---] engagements


"#Novonordisk $nvo Lilly highlights dramatic weight loss - roughly similar to Novos - while downplaying the high rate of side effects. The real benefit seems to be its impact on knee osteoarthritis. Yet the press release sells hype over honesty"  
[X Link](https://x.com/janthecurious1/status/1999106800981815326)  2025-12-11T13:19Z [---] followers, [---] engagements


"#Novonordisk $nvo More good news EMA has issued a positive opinion for Wegovy [---] mg. The higher dose shows up to 20.7% average weight loss while preserving muscle function bringing it one step closer to EU approval"  
[X Link](https://x.com/janthecurious1/status/1999488465952796875)  2025-12-12T14:36Z [---] followers, [---] engagements


"#novonordisk $nvo I view Novo Nordisks FDA filing for CagriSema as a major milestone - it is the first once-weekly combination of GLP-1 and amylin for obesity. The clinical efficacy is exceptionally strong with up to 23% average weight loss in phase [--] clearly outperforming semaglutide alone. As a first-in-class combination CagriSema meaningfully differentiates Novo Nordisk and raises competitive barriers. The obesity market is large fast-growing and supports premium pricing with potential for long-term chronic use. If approved in [----] I see CagriSema as a potential new blockbuster that can"  
[X Link](https://x.com/janthecurious1/status/2001664000673607805)  2025-12-18T14:41Z [---] followers, [----] engagements


"#novonordisk $nvo Approval will come. Until then Novo is celebrating the holidays 🎄"  
[X Link](https://x.com/janthecurious1/status/2003145719788765292)  2025-12-22T16:48Z [---] followers, [----] engagements


"Im a long-term shareholder in Novo Nordisk. The oral Wegovy pill can be sold from January - everything is prepared and production has been running for months. A higher Wegovy dose is coming later this year. This isnt hype its execution and a multi-year earnings ramp. #novonordisk $nvo https://twitter.com/i/web/status/2003367221557350691 https://twitter.com/i/web/status/2003367221557350691"  
[X Link](https://x.com/janthecurious1/status/2003367221557350691)  2025-12-23T07:29Z [---] followers, [---] engagements


"#novonordisk $nvo Consensus still repeats: Patent expiry = massive hit to Novo. Thats lazy analysis. Semaglutide isnt a copy-paste pill - its largescale industrial biotech. Manufacturing stability device design and global supply chains are extremely hard to replicate. Novo is [----] years ahead. With prices now at levels where patients choose proven safety over copies the risk that generics never become commercially meaningful is massively underestimated. Heres another Potential big Christmas present for $NVO if true. That launch of biosimilars In Canada is pushed plus [--] months back $LLY $VKTX"  
[X Link](https://x.com/janthecurious1/status/2003777425826587038)  2025-12-24T10:39Z [---] followers, [---] engagements


"$nvo 3x 🚀📈 I think many people underestimate whats happening. According to Reuters Novo Nordisks GLP-1 pill isnt just another blockbuster drug - its already reshaping how Americans eat: smaller portions fewer snacks more protein. When medicine starts shifting demand across the entire food industry youre playing in a completely different league. #NovoNordisk #GLP1 #Wegovy #Disruption #FoodIndustry #ConsumerBehavior #HealthEconomics https://twitter.com/i/web/status/2004270786807583174 https://twitter.com/i/web/status/2004270786807583174"  
[X Link](https://x.com/janthecurious1/status/2004270786807583174)  2025-12-25T19:19Z [---] followers, [----] engagements


"#Novonordisk $nvo Im clearly more bullish than the market. With the Wegovy pill Novo Nordisk is rolling out an extremely scalable U.S. commercial model: 70000+ pharmacies strong telehealth channels and aggressive self-pay pricing. I dont think the pessimistic analyst price targets will hold - in my view the sell-side will start raising them again within a week. And it likely wont be long before buybacks and dividends are back on the agenda. 📈🚀 https://twitter.com/i/web/status/2008171776128299456 https://twitter.com/i/web/status/2008171776128299456"  
[X Link](https://x.com/janthecurious1/status/2008171776128299456)  2026-01-05T13:40Z [---] followers, [---] engagements


"Wild to see employer-paid Wegovy in the US. As I understand it its already a reality for some employers - and a clear megatrend for many more. In [--] years its likely to be far more widespread especially now that Novo can document long-term savings through fewer sick days and better health outcomes"  
[X Link](https://x.com/janthecurious1/status/2010387512217202973)  2026-01-11T16:25Z [---] followers, [---] engagements


"#novonordisk $nvo Novo was first in obesity treatment - and now first with the pill. The first-mover advantage is real and massive. When people have a choice they choose the original - and most can afford it now. $NVO Vice President: "We are seeing tremendous demand for the Wegovy pill." $NVO will dominate the oral weight loss drug market. They are establishing early dominance and $LLY will have a hard time catching up this time as $NVO has a better product. https://t.co/lgmoPLfTor $NVO Vice President: "We are seeing tremendous demand for the Wegovy pill." $NVO will dominate the oral weight"  
[X Link](https://x.com/janthecurious1/status/2010946573975388438)  2026-01-13T05:26Z [---] followers, [---] engagements


"#novonordisk $nvo Dave Moore Novo: There are so many patients that have been on the sidelines just waiting because they didnt really see themselves treating with an injection. Now that the pill is available we are seeing a lot of excitement and a lot of activity. https://www.foxbusiness.com/media/novo-nordisk-executive-reports-high-interest-once-daily-oral-weight-loss-pill https://www.foxbusiness.com/media/novo-nordisk-executive-reports-high-interest-once-daily-oral-weight-loss-pill"  
[X Link](https://x.com/janthecurious1/status/2010956665609216502)  2026-01-13T06:06Z [---] followers, [---] engagements


"#Novonordisk $nvo There has been a lot of noise around copy or compounded GLP-1 products in the US. Its worth focusing on what Novo actually said at the J.P. Morgan Healthcare Conference - and what it didnt. Novo executive Mike Doustdar acknowledged that roughly [---] million US patients are currently using compounded GLP-1 products. Not because they prefer unsafe knock-offs but because they are highly price-sensitive. Direct quote (Reuters): Its not because this one-and-a-half million patients like to have unsafe knock-off versions of our products they grabbed a part of the consumers that"  
[X Link](https://x.com/janthecurious1/status/2010969577014931604)  2026-01-13T06:58Z [---] followers, [---] engagements


"#novonordisk $nvo Now let's see getting up to [---] 😀📈"  
[X Link](https://x.com/janthecurious1/status/2011082735402819880)  2026-01-13T14:27Z [---] followers, [---] engagements


"Interesting to hear criticism from Novo when Lillys pill also requires waiting time with other medications typically statins for high cholesterol. Novos tablet requires only [--] minutes on an empty stomach. Lillys recommendation is [--] hours. That perspective is completely missing"  
[X Link](https://x.com/janthecurious1/status/2011188793836224921)  2026-01-13T21:29Z [---] followers, [--] engagements


"#novonordisk $nvo The U.S. is moving toward tighter regulation of unauthorized compounded GLP-1 copy products. Officially driven by patient safety but with clear market implications. Novo Nordisk estimates that around [---] million Americans are currently using non-FDA-approved GLP-1 copies often with uncertain quality dosing and safety. Regulators and lawmakers are now responding to a growing parallel market which could materially impact demand margins and long-term value for approved GLP-1 therapies. Source (Reuters):"  
[X Link](https://x.com/janthecurious1/status/2011319392605200786)  2026-01-14T06:08Z [---] followers, [--] engagements


"#novonordisk $nvo The U.S. is moving toward tighter regulation of unauthorized compounded GLP-1 copy products. Officially driven by patient safety but with clear market implications. Novo Nordisk estimates that around [---] million Americans are currently using non-FDA-approved GLP-1 copies often with uncertain quality dosing and safety. Regulators and lawmakers are now responding to a growing parallel market which could materially impact demand margins and long-term value for approved GLP-1 therapies. Source (Reuters):"  
[X Link](https://x.com/janthecurious1/status/2011319421285879910)  2026-01-14T06:08Z [---] followers, [--] engagements


"$nvo The U.S. is increasing scrutiny of unauthorized compounded GLP-1 copy products amid growing patient safety concerns. Novo Nordisk estimates that around [---] million Americans are currently using non-FDA-approved GLP-1 copies often with uncertain quality dosing and safety. Separately the FDA has issued warnings and enforcement actions against compounded GLP-1 products that are marketed as equivalents to approved drugs highlighting risks to patients and regulatory non-compliance. Sources: Novo Nordisk estimate (Reuters): FDA on compounded GLP-1 risks:"  
[X Link](https://x.com/janthecurious1/status/2011320563441062006)  2026-01-14T06:12Z [---] followers, [---] engagements


"@ResearchPulse1 $NVO Early Phase [--] registration of AMAZE [--] reinforces Amycretin as a top-priority obesity asset. Long P3 design targets best-in-class durability"  
[X Link](https://x.com/janthecurious1/status/2011451726482796735)  2026-01-14T14:53Z [---] followers, [---] engagements


"@ResearchPulse1 Thank you so much for sharing your knowledge. Patience must have been the key at the moment. It's a huge logistical task Novo has going on. I've heard from the water pipes that the employees have never been so busy - so Mike and Lars' collaboration works"  
[X Link](https://x.com/janthecurious1/status/2012110825041822198)  2026-01-16T10:32Z [---] followers, [---] engagements


"The big investors are gradually immune to all the tariff threats. Threatened China for example and they were subsequently put on hold. The investors probably also expect that all his tariffs will be declared illegal by the US Supreme Court. Completely unreasonable. I wonder if we will close the gap to the US of 2-3% https://twitter.com/i/web/status/2012826600002253289 https://twitter.com/i/web/status/2012826600002253289"  
[X Link](https://x.com/janthecurious1/status/2012826600002253289)  2026-01-18T09:57Z [---] followers, [---] engagements


"JPMorgan: The Greenland issue gets resolved this week. Not through escalation but a deal: Davos-style: The US gets access Greenland gets investment Denmark keeps sovereignty No crisis. Just a transaction. Bullish of course $nvo 📈🚀🚀🚀 Why JPMorgan's Desk Thinks The Greenland Standoff Ends In A Bullish "Negotiated Arranagement" https://t.co/FkG1fsCoeP Why JPMorgan's Desk Thinks The Greenland Standoff Ends In A Bullish "Negotiated Arranagement" https://t.co/FkG1fsCoeP"  
[X Link](https://x.com/janthecurious1/status/2013544225304899941)  2026-01-20T09:28Z [---] followers, [---] engagements


"@ResearchPulse1 Amycretin is going to be huge for Novo and everything is going perfectly so far"  
[X Link](https://x.com/janthecurious1/status/2014244048895090993)  2026-01-22T07:49Z [---] followers, [--] engagements


"$GRVY The ultimate owner of Gravity is Softbank Group. New fresh eyes on the ownership of Gravity and or the dividend policy could be exciting. 😀🙏 https://www.japantimes.co.jp/news/2022/06/22/business/corporate-business/michel-combes-softbank-international/ https://www.japantimes.co.jp/news/2022/06/22/business/corporate-business/michel-combes-softbank-international/"  
[X Link](https://x.com/janthecurious1/status/1539619208237121537)  2022-06-22T14:39Z [---] followers, [--] engagements


"@bruuntonny Gravity has said on several occasions that it will not be in [----]. I would think that at some point the shareholders of GungHo will demand that all the hidden values in Gravity be released. In [----] Will only come in connection with the annual report 😀"  
[X Link](https://x.com/janthecurious1/status/1554066561195032579)  2022-08-01T11:28Z [---] followers, [--] engagements


"@bruuntonny Maybe Morgan Stanley is shaking the tree for support of GungHo Morgan Stanley has been selling off for a long time. The tendency has also been that private individuals to sell out to institutional investors. Be patient"  
[X Link](https://x.com/janthecurious1/status/1602410249117437982)  2022-12-12T21:09Z [---] followers, [--] engagements


"@mads_sparholt SON= SoftBank. Like other shareholders they need a return on investment. Why would they turn a blind eye to the possibility of cash from Gravity"  
[X Link](https://x.com/janthecurious1/status/1689708205151035392)  2023-08-10T18:40Z [---] followers, [---] engagements


"$Grvy Many here on Twitter write about GungHo having total power over Gravity. They have but Gravity is subject to a wide range of laws in the US and South Korea that protect the miniotet shareholders. GungHo Online Entertainment Inc. owns [-----] of the shares 1/x"  
[X Link](https://x.com/janthecurious1/status/1798407042324980183)  2024-06-05T17:30Z [---] followers, [---] engagements


"@freddiewittmann The **Grandia HD Collection** has indeed been released for the PlayStation [--] and PlayStation [--]. Published by GungHo Online Entertainment the collection became available on March [--] [----]. Not Gravity Co. 😀"  
[X Link](https://x.com/janthecurious1/status/1816904876246421543)  2024-07-26T18:34Z [---] followers, [---] engagements


"$Grvy Strategic Capital has acquired a significant stake in Gravitys parent company GungHo Online Entertainment. This may suggest they are also in the process of acquiring shares in Gravity According to an EDINET report related to a large shareholding in GungHo Online Entertainment Strategic Capital Co. Ltd. () has acquired [-------] shares representing 5.47% of GungHos total shares as of October [--] [----]. https://twitter.com/i/web/status/1846926485631737976 https://twitter.com/i/web/status/1846926485631737976"  
[X Link](https://x.com/janthecurious1/status/1846926485631737976)  2024-10-17T14:49Z [---] followers, 19.1K engagements


"$Grvy Strategic Capital Inc. and GungHo: A Potential Shift in Power Dynamics As many of you may know the activist fund Strategic Capital Inc. has recently invested in GungHo Online Entertainment the parent company of Gravity acquiring a significant stake of 5.475%. This investment positions them to potentially influence the power dynamics within the company. This is a major development that could impact decision-making and capital allocation within GungHo and by extension within Gravity. Strategic Capital has recognized the same opportunities that we have: There are substantial untapped"  
[X Link](https://x.com/janthecurious1/status/1859248007016825161)  2024-11-20T14:50Z [---] followers, [---] engagements


"$Grvy 2025.02.14 #GungHo The parent company GungHo is changing its dividend policy for the group to ensure a more equitable distribution among shareholders. The activist fund Strategic Capitals initiative has paid off. It sounds like this change might also apply to Gravity as they are part of the group but Im not sure. Positive to see that GungHos management is listening to its shareholders. https://stracap.jp https://stracap.jp"  
[X Link](https://x.com/janthecurious1/status/1890323140565139828)  2025-02-14T08:52Z [---] followers, [----] engagements


"$Grvy #GungHo Turning Pressure into Potential: Why GungHo and Gravity May Be on the Verge of Unlocking Shareholder Value Following recent unrest at GungHo Online Entertainments general meeting and a set of activist shareholder proposals from Strategic Capital investors are rightly asking: What now And more importantly: What does this mean for shareholders in both GungHo and its subsidiary Gravity Co. Ltd. At first glance the proposals were all unanimously rejected by the boardmost notably the call to review CEO Kazuki Morishitas rapidly increasing compensation. But it would be wrong to"  
[X Link](https://x.com/janthecurious1/status/1909627049813123559)  2025-04-08T15:19Z [---] followers, [----] engagements


"$Grvy Strategic Capital increases pressure on GungHo and theres still more to unlock Although GungHo Online Entertainment made some concessions to investor demands in February including adjusting its executive compensation policy and introducing new capital allocation strategies the pressure from Strategic Capital has not subsided. Behind the numbers lie significant unrealized values especially in its subsidiary Gravity. Gravity has for years delivered strong results with its Ragnarok Online franchise and indicators point to continued growth in both game revenues and global licensing income."  
[X Link](https://x.com/janthecurious1/status/1919466734395765060)  2025-05-05T18:58Z [---] followers, [----] engagements


"$Grvy #GungHo President & Chief Executive Officer (CEO) of GungHo Online Entertainment Inc. is Kazuki Morishita @kazukimorishita Kazuki is now under great pressure from Strategic Capital Japan. Hopefully we will see the price of Gravity soon be at a normal level of 120- [---] 😀🙏 Explaining why SC is now taking the bold step of demanding the CEOs dismissal SC representative Tsuyoshi Maruki stated: GungHos board judging from the voting results in March appears to be avoiding serious discussions about the companys future. We want them to understand that action must be taken including"  
[X Link](https://x.com/janthecurious1/status/1948041788612104296)  2025-07-23T15:25Z [---] followers, [----] engagements


"#novonordisk $nvo The pill brings Novo back. CagriSema locks Novo into the 2030s. Phase [--] data is in (20% weight loss). Launch expected late [----]. New combination IP - difficult to copy difficult to compound. GLP-1 + amylin is proven. Not a product. A platform. Protected. Scalable. Hard to displace. $NVO IS THE MOST UNDERVALUED STOCK Revenue and net-margin will continue to grow from here yet the company is basically priced for failure. A [----] P/E is absolutely ridiculous and nobody can tell me otherwise. This is one of these obvious buys that most people will still https://t.co/stEj22GDMq"  
[X Link](https://x.com/janthecurious1/status/2009479210465624399)  2026-01-09T04:15Z [---] followers, [----] engagements


"#novonordisk $novo The wind has changed direction. 🚀🚀🚀"  
[X Link](https://x.com/janthecurious1/status/2012125987639865492)  2026-01-16T11:33Z [---] followers, [---] engagements


"#novonordisk $nvo I don't understand technical analysis. But others do. The next stop is around [--] this analysis says P/E [--] is crazy - should be around double that for such a quality company - Financial statements February [--] [----] 🚀🚀📈📈"  
[X Link](https://x.com/janthecurious1/status/2012499046934405451)  2026-01-17T12:15Z [---] followers, [---] engagements


"#novonordisk $nvo The market is missing the point entirely. Novo Nordisks oral Wegovy pill is produced 100% in the US - from start to finish in North Carolina. No imports. No tariffs. No tariff risk. On top of that Novo is further shielded under the Trump administrations MFN framework which explicitly favors and protects local US manufacturing. This is a structural advantage not a footnote. #NVO #Wegovy #Pharma #Tariffs https://www.wral.com/news/state/wegovy-pill-made-in-north-carolina-december-2025/ https://twitter.com/i/web/status/2013536254848053318"  
[X Link](https://x.com/janthecurious1/status/2013536254848053318)  2026-01-20T08:57Z [---] followers, [---] engagements


"#novonordisk $nvo Novo Nordisk strengthens its position in the fight against type [--] diabetes through a smart strategic move in next-generation drug development: Reduced organizational complexity and management load Access to cutting-edge cell therapy platforms Upside through equity ownership royalties and milestones Limited risk Aspect leads drug development and manufacturing Option to increase involvement later if clinical data delivers Focus on developing a potential functional cure rather than lifelong treatment Strategic. Long-term. Classic Novo strategy."  
[X Link](https://x.com/janthecurious1/status/2013618250299400357)  2026-01-20T14:22Z [---] followers, [---] engagements


"#novonordisk $nvo Oral Wegovy launches far above expectations. If momentum holds [----] guidance upgrade https://bingx.com/en/news/post/novo-nordisk-shares-climb-as-oral-wegovy-hits-first-week-prescriptions-and-goldman-issues-buy-rating https://bingx.com/en/news/post/novo-nordisk-shares-climb-as-oral-wegovy-hits-first-week-prescriptions-and-goldman-issues-buy-rating"  
[X Link](https://x.com/janthecurious1/status/2015866214430417258)  2026-01-26T19:15Z [---] followers, [---] engagements


"@investseekers Very positive for $nvo #NovoNordisk: #MASH market is now clearly validated More competition is fine - Novo is among the frontrunners Rising probability that MASH becomes a very large market"  
[X Link](https://x.com/janthecurious1/status/2016595079100567873)  2026-01-28T19:31Z [---] followers, [---] engagements


"#novonordisk $nvo The core message from Novo Nordisks top leadership: the company performs best in headwinds. Rebuilding culture with trust fighting spirit and an end to perfectionism is key. Several new products are on the way and lower prices are meant to expand the market for patients. Berlingske was the only Danish media present. https://www.berlingske.dk/virksomheder/onsdag-eftermiddag-forsoegte-lars-rebien-og-mike-doustdar-at-genoplive-novo-aanden--her-er-hvad-de-sagde"  
[X Link](https://x.com/janthecurious1/status/2016606131775258774)  2026-01-28T20:15Z [---] followers, [---] engagements


"#Novonordisk $nvo People still think GLP-1 adoption is done. Its not. Ro is about to activate millions of men whove been scared of the needle the doctor and the label. Super Bowl + Serena Williams = stigma collapse at scale. 150M eyeballs. Explosive demand response. This is how new healthcare markets are forced open. The story is unique. And millions of people will achieve better health live longer and have greater joy in life. https://t.co/bnxvBTWk45 https://t.co/bnxvBTWk45"  
[X Link](https://x.com/janthecurious1/status/2016882575701110994)  2026-01-29T14:34Z [---] followers, [---] engagements


"@Kuenni_SK @investseekers There are heavy snowstorms and parts of the US are experiencing power outages. So that's definitely having an impact"  
[X Link](https://x.com/janthecurious1/status/2017238426370654692)  2026-01-30T14:08Z [---] followers, [--] engagements


"Typical strategy for new people on the bridge to blame the old management and come up with a very conservative budget where they have also changed principles to make the forecast look even more negative. Believe in more upward adjustments in [----]. The pill cannot be stopped now and it is expanding the market to men as the CFO said today. https://twitter.com/i/web/status/2018805532749119879 https://twitter.com/i/web/status/2018805532749119879"  
[X Link](https://x.com/janthecurious1/status/2018805532749119879)  2026-02-03T21:55Z [---] followers, [---] engagements


"@A_May_MD Scam again. Must be a publicity stunt. A last-ditch attempt to avoid the stock collapsing completely before the Super Bowl"  
[X Link](https://x.com/janthecurious1/status/2019438658693075445)  2026-02-05T15:51Z [---] followers, [---] engagements


"The management is selling shares all the time and the CEO has sold very large points. The stock is severely shorted. I wonder if it is facing a collapse. Must be the last attempts here in the Super Bowl to keep the share price up. Scam company with a former director from Novo on the board. https://twitter.com/i/web/status/2019460541371035808 https://twitter.com/i/web/status/2019460541371035808"  
[X Link](https://x.com/janthecurious1/status/2019460541371035808)  2026-02-05T17:18Z [---] followers, [---] engagements


"@ResearchPulse1 40% short interest. Collapse incoming"  
[X Link](https://x.com/janthecurious1/status/2019654271097299228)  2026-02-06T06:07Z [---] followers, [---] engagements


"@ResearchPulse1 Zealand Pharma A/S the Danish biotech company also has development programs within obesity. 👉 CEO Adam Steensberg will give a presentation and take part in a fireside chat: Wednesday January [--] 2026"  
[X Link](https://x.com/janthecurious1/status/2010358011819147701)  2026-01-11T14:27Z [---] followers, [---] engagements


"Short answer: Yes it is technically realistic for Novo Nordisk to acquire Zealand Pharma Novo has both the financial capacity and a strategic interest. However at the moment it is not the most likely scenario as Zealand has instead chosen to enter into collaboration agreements including with Roche. Zealand is also flush with cash. It is odd that they are not using some of that cash for share buybacks. I hope there will be some positive news next week. The market value of Zealand should be double what it is. https://twitter.com/i/web/status/2010381660676563338"  
[X Link](https://x.com/janthecurious1/status/2010381660676563338)  2026-01-11T16:01Z [---] followers, [---] engagements


"This is about a deliberate change in principle. CEO Mike Doustdar has changed the guidance methodology and now excludes sales rebates from the forecast. If rebates were included: [----] sales: approx. 1% Operating profit: approx. +11% - which is very strong. Guidance is set extremely conservatively. An upgrade looks like a question of when. https://twitter.com/i/web/status/2018754961027289527 https://twitter.com/i/web/status/2018754961027289527"  
[X Link](https://x.com/janthecurious1/status/2018754961027289527)  2026-02-03T18:34Z [---] followers, [---] engagements


"On top of the sad Outlook [----] from Novo today it's a pleasure to hear about the journey for @serenawilliams with @ro and Wegovy. Role model for other people. The GOAT @serenawilliams sits down with the one and only @Oprah to talk about her health journey on @ro. SW is such an inspiration and hearing her story directly from her hits different. Check out the full conversation on The Oprah Podcast here: https://t.co/36KLOEpuWv The GOAT @serenawilliams sits down with the one and only @Oprah to talk about her health journey on @ro. SW is such an inspiration and hearing her story directly from her"  
[X Link](https://x.com/janthecurious1/status/2019076273121742991)  2026-02-04T15:51Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing